Literature DB >> 2962936

Sequence polymorphism of human complement factor H.

A J Day1, A C Willis, J Ripoche, R B Sim.   

Abstract

Factor H is a major regulatory protein of the complement system. The complete cDNA coding sequence has been derived from overlapping clones, and a polymorphism at base 1277 has been characterized. In four clones there is a T at nucleotide 1277 and in two others there is a C. This T/C change represents a tyrosine/histidine polymorphism at position 384 in the derived amino acid sequence. Protein sequence studies on peptides generated by trypsin digestion of factor H, purified from pooled plasma from 12 donors, confirmed the presence of both tyrosine and histidine at this position. Tyrosine and histidine were observed in a ratio of 2:1, respectively, and therefore this polymorphism is likely to represent a sequence difference between the two most abundant charge variants, FH1 and FH2, of factor H.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2962936     DOI: 10.1007/BF00346588

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  14 in total

1.  Structural analysis of human complement protein H: homology with C4b binding protein, beta 2-glycoprotein I, and the Ba fragment of B2.

Authors:  T Kristensen; R A Wetsel; B F Tack
Journal:  J Immunol       Date:  1986-05-01       Impact factor: 5.422

2.  New alleles of C4-binding protein and factor H and further linkage data in the regulator of complement activation (RCA) gene cluster in man.

Authors:  S Rodriguez de Cordoba; P Rubinstein
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

3.  Factor D of the alternative pathway of human complement. Purification, alignment and N-terminal amino acid sequences of the major cyanogen bromide fragments, and localization of the serine residue at the active site.

Authors:  D M Johnson; J Gagnon; K B Reid
Journal:  Biochem J       Date:  1980-06-01       Impact factor: 3.857

4.  Isolation, characterization and N-terminal sequences of the CNBr-cleavage peptides from human complement Factor B. Localization of a free thiol group and a sequence defining the site cleaved by factor D.

Authors:  D L Christie; J Gagnon
Journal:  Biochem J       Date:  1982-03-01       Impact factor: 3.857

5.  A gas-liquid solid phase peptide and protein sequenator.

Authors:  R M Hewick; M W Hunkapiller; L E Hood; W J Dreyer
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

6.  Sequence of the amino-terminal 349 residues of rabbit muscle glycogen phosphorylase including the sites of covalent and allosteric control.

Authors:  A Koide; K Titani; L H Ericsson; S Kumar; H Neurath; K A Walsh
Journal:  Biochemistry       Date:  1978-12-26       Impact factor: 3.162

7.  Sequence analysis of a cDNA clone encoding the C-terminal end of human complement factor H.

Authors:  A J Day; J Ripoche; A Lyons; B McIntosh; T J Harris; R B Sim
Journal:  Biosci Rep       Date:  1987-03       Impact factor: 3.840

8.  Purification and structural studies on the complement-system control protein beta 1H (Factor H).

Authors:  R B Sim; R G DiScipio
Journal:  Biochem J       Date:  1982-08-01       Impact factor: 3.857

9.  Human complement factor H: isolation of cDNA clones and partial cDNA sequence of the 38-kDa tryptic fragment containing the binding site for C3b.

Authors:  T F Schulz; W Schwäble; K K Stanley; E Weiss; M P Dierich
Journal:  Eur J Immunol       Date:  1986-11       Impact factor: 5.532

10.  Quantitative variations of the C3b/C4b receptor (CR1) in human erythrocytes are controlled by genes within the regulator of complement activation (RCA) gene cluster.

Authors:  S Rodriguez de Cordoba; P Rubinstein
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  21 in total

1.  Polymorphism and deficiency of human factor H-related proteins p39 and p37.

Authors:  E Feifel; W M Prodinger; M Mölgg; W Schwaeble; D Schönitzer; V Koistinen; R Misasi; M P Dierich
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina.

Authors:  Simon J Clark; Rahat Perveen; Svetlana Hakobyan; B Paul Morgan; Robert B Sim; Paul N Bishop; Anthony J Day
Journal:  J Biol Chem       Date:  2010-07-26       Impact factor: 5.157

3.  Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation.

Authors:  Andreas P Sjöberg; Gavin A Manderson; Matthias Mörgelin; Anthony J Day; Dick Heinegård; Anna M Blom
Journal:  Mol Immunol       Date:  2008-10-29       Impact factor: 4.407

4.  The ARMS2 A69S Polymorphism Is Associated with Delayed Rod-Mediated Dark Adaptation in Eyes at Risk for Incident Age-Related Macular Degeneration.

Authors:  Robert F Mullins; Gerald McGwin; Karen Searcey; Mark E Clark; Elizabeth L Kennedy; Christine A Curcio; Edwin M Stone; Cynthia Owsley
Journal:  Ophthalmology       Date:  2018-10-31       Impact factor: 12.079

Review 5.  The role of complement in age-related macular degeneration: heparan sulphate, a ZIP code for complement factor H?

Authors:  Alex Langford-Smith; Tiarnan D L Keenan; Simon J Clark; Paul N Bishop; Anthony J Day
Journal:  J Innate Immun       Date:  2013-12-07       Impact factor: 7.349

6.  Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions.

Authors:  Simon J Clark; Liam A Ridge; Andrew P Herbert; Svetlana Hakobyan; Barbara Mulloy; Rachel Lennon; Reinhard Würzner; B Paul Morgan; Dusan Uhrín; Paul N Bishop; Anthony J Day
Journal:  J Immunol       Date:  2013-01-30       Impact factor: 5.422

Review 7.  Genetic variants in the complement system predisposing to age-related macular degeneration: a review.

Authors:  Elizabeth C Schramm; Simon J Clark; Michael P Triebwasser; Soumya Raychaudhuri; Johanna Seddon; John P Atkinson
Journal:  Mol Immunol       Date:  2014-07-15       Impact factor: 4.407

8.  A Personal Tribute to Robert B. Sim with Reflections on Our Work Together on Factor H.

Authors:  Anthony J Day
Journal:  Viruses       Date:  2021-06-28       Impact factor: 5.048

9.  Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules.

Authors:  Steven Johnson; Lionel Tan; Stijn van der Veen; Joseph Caesar; Elena Goicoechea De Jorge; Rachel J Harding; Xilian Bai; Rachel M Exley; Philip N Ward; Nicola Ruivo; Kaushali Trivedi; Elspeth Cumber; Rhian Jones; Luke Newham; David Staunton; Rafael Ufret-Vincenty; Ray Borrow; Matthew C Pickering; Susan M Lea; Christoph M Tang
Journal:  PLoS Pathog       Date:  2012-10-25       Impact factor: 6.823

10.  Identification of factor H-like protein 1 as the predominant complement regulator in Bruch's membrane: implications for age-related macular degeneration.

Authors:  Simon J Clark; Christoph Q Schmidt; Anne M White; Svetlana Hakobyan; B Paul Morgan; Paul N Bishop
Journal:  J Immunol       Date:  2014-10-10       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.